期刊文献+

华法林致咯血1例 被引量:1

下载PDF
导出
摘要 华法林是常用口服抗凝剂,其作用机制是主要影响外源性凝血系统,与维生素K相互竞争,抑制部分凝血因子的合成过程,使凝血因子合成减少,发挥抗凝作用,但过量或使用方法不当又会导致出血。出血发生率取决于抗凝程度、用药持续时间、患者的情况、实验室检测的准确度以及药物之间的反应[1]等,其处理方法是采用维生素K和输新鲜血浆治疗。高安市人民医院收治华法林致咯血1例,报告如下。
出处 《实用临床医学(江西)》 CAS 2014年第7期25-26,共2页 Practical Clinical Medicine
  • 相关文献

参考文献7

  • 1张倩辉,高丽君,李树仁,郭艺芳.2010版欧洲心房颤动诊疗指南解读[J].心血管病学进展,2011,32(5):630-632. 被引量:26
  • 2王立立,陈淑霞,韩玉平.心房颤动药物抗凝治疗的最新进展[J].临床荟萃,2012,27(22):2021-2024. 被引量:4
  • 3Aagaard J, Tingleff J, Hansen C N, et al.Twelve years' cli- nical experience with the carbomedics prosthetic heart valve[J].J Heart Valve Dis,2001,10(2) : 177-184.
  • 4Fuster V,Rydon L E,Cannom D S,et al.2011 ACCF/A- HA/HRS focused updates incorporated into the ACC/A- HA/ESC 2006 guidelines for the management of patients with atrial fibrillation : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines [J ] .Circulation, 2011,123 (10) : e269-e367.
  • 5Hirsh J,Guyatt G,Albers G W,et al.Antithrombotic and thrombolytic therapy :American College of Chest Physi- cians Evidence-based clinical practice guidelines (8th Edition) [J].Chest,2008,133(S 6) :S110-S112.
  • 6Ansell J, Hirsh J, Hylek E, et al.Pharmacology and man- agement of the vitamin K antagonists:American College of Chest Physicians Evidence-based clinical practice gu- idelines (8th Edition)[J].Chest,2008,133 (S 6):S160- S198.
  • 7Home B D,Lenzini P A,Wadelius M,et al.Pharmacoge- netic warfarin dose refinements remain significantly influ- enced by genetic factors after one week of therapy [J]. Thromb Haemost, 2012,107 (2) : 232-240.

二级参考文献12

  • 1Go AS, H ylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study[J]. JAMA, 2001,285 (18) :2370-2375.
  • 2Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of a trial fibrillation: the Task Foree for the Managementtof Atrial Fibrillation of the European Society of Cardiology(ESC) [J]. Eur Heart J,2010,31(19) : 2369-2429.
  • 3Pister R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess l-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey[J]. Chest,2010,138(5) : 1093-1100.
  • 4Lip GY, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulant patients with atrial fibrillation : the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score[J]. J Am Coll Cardiol, 2011,57(2) : 173-180.
  • 5Hart RG, Pearee LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Am Intern Med, 2007, 146 (12) :857-867.
  • 6Nieuwlaat R, Capucci A, I.ip GY, et al. Antithrombotie treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation[J]. Eur Heart J, 2006,27( 24), 3018-3026.
  • 7Connolly SJ ,Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009,361(12) :1139-1151.
  • 8Albers GW, Diener HC, Frison L, et al. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation : a randomized trial[J]. J AMA, 2005,293 (6): 690-698.
  • 9Amadeus Investigators, Bousser MG, Bouthier J, et al. Comparison of idraparinux with vitamin K antagonists {or prevention of thromboembolism in patients with atrialfibrillation: a randomized, open label, non-inferiority trial[J]. Lancet,2008,371(9609) :315 -321.
  • 10ROCKET AF study Investigators. Rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rational and design of the ROCKET AF study[J]. Am Heart J,2010,159(3) :340-347.

共引文献28

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部